This morning (April 12), the China National Chemical Corporation, known as ChemChina, and Syngenta announced that they have received approval from the Ministry of Commerce of the People’s Republic of China for the proposed acquisition of Syngenta by ChemChina — at $43 billion, it’s the largest foreign acquisition by a Chinese company._x000D_
_x000D_
In a statement, the companies note that this approval represents another step toward closing the transaction, which is expected in the second quarter of 2017._x000D_
_x000D_
Last week the U.S. and European Union competition authorities gave conditional approval of the deal, which was followed by Mexico’s approval earlier this week. India has not yet signed off on the deal._x000D_
_x000D_
Under the conditions set by the U.S. Federal Trade Commission, Syngenta must divest three pesticides: paraquat, abamectin and chlorothalonil. Syngenta owns the branded version of each of the three products, giving it significant market shares in the United States. ChemChina’s subsidiary ADAMA focuses on generic pesticides and is either the first- or second-largest generic supplier in the United States for each of these products._x000D_
_x000D_
The FTC believes that “without the proposed divestiture, the merger would eliminate the direct competition that exists today between ChemChina generics subsidiary ADAMA and Syngenta’s branded products. The merger would also increase the likelihood that U.S. customers buying paraquat, abamectin, and chlorothalonil would be forced to pay higher prices or accept reduced service for these products.”_x000D_
_x000D_
The proposed settlement requires ChemChina to sell all rights and assets of ADAMA’s U.S. paraquat, abamectin and chlorothalonil crop protection businesses to California-based agrochemical company AMVAC._x000D_
_x000D_
